AI is at the forefront of AI-assisted development, revolutionizing the formulation and delivery of bioactive compounds through advanced delivery platforms. Our expertise spans AI-integrated liposomal systems, micellar formulations, self-emulsifying drug delivery systems (SEDDS), and other next-generation technologies. By harnessing artificial intelligence, we enhance bioavailability, stability, and precision-targeted delivery, ensuring superior formulation development.
At AI, we merge scientific expertise with cutting-edge AI-driven insights to accelerate innovation and streamline product development. Our solutions redefine the future of smart delivery systems in pharmaceuticals and nutraceuticals, driving efficiency, precision, and unparalleled bioactive compound performance.
Partner with us to revolutionize the science of bioactive delivery.
Our research and development centres extend across India, Australia, and the USA, driving innovation on a global scale. , and as a result of our R&D efforts, we have successfully developed a variety of products, processes, and technologies for various therapeutic segments.
Research on new products and drug delivery platforms such as liposomal encapsulation, controlled delivery systems, multi-layer tablet systems, and liposomal gummy technologies are among our R&D activities. AI has developed and filed globally relevant dossiers with partners in emerging and regulated markets. Furthermore, we are able to effectively formulate difficult products across a wide range of therapeutic and nutraceutical categories using our in-house developed technology platforms.